Earnings History Data for Abbott Laboratories (ABT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Abbott Laboratories

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
16-10-2024	PM		ABT	Abbott Laboratories	204,000	1.21	1.20	1.14	Abbott Laboratories Non-GAAP EPS of $1.21 beats by $0.01, revenue of $10.64B beats by $90M [10/16/2024 7:32 AM]	117.82	1.77 (1.53%)	117.83	1.78 (1.53%)	90.87 - 121.64	5,946,611	4,460,000	122,588
Abbott Laboratories Q3 Earnings Preview: Profit boost expected [10/15/2024 2:02 PM] Abbott Laboratories Non-GAAP EPS of $1.21 beats by $0.01, revenue of $10.64B beats by $90M [10/16/2024 7:32 AM] Earnings Snapshot: Abbott Laboratories beats consensus in Q3, tightens FY2024 outlook [10/16/2024 7:48 AM] Abbott in charts: Medical Devices sales sustain double-digit Y/Y growth with an 11.7% rise in Q3 [10/16/2024 7:59 AM] Abbott raises earnings outlook as MedTech, Pharma drive Q3 beat [10/16/2024 8:21 AM] Jim Cramer Says That FDA, NIH, and CDC Comments On Abbott Laboratories (ABT) Could Potential Help The Stock Going Forward [Oct-15-24 11:48AM] Is a Surprise Coming for Abbott (ABT) This Earnings Season? [Oct-15-24 08:46AM] Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range [2024-10-16 07:30AM] Cramer's Stop Trading: Abbott Labs [2024-10-16 10:49AM] The Art of Valuation: Discovering Abbott Laboratories's Intrinsic Value [2024-10-16 08:00AM] Abbott Laboratories Boosts FY24 Earnings Outlook - Update [2024-10-16 07:47AM] Abbott: Q3 Earnings Snapshot [2024-10-16 07:38AM] Abbott slightly raises profit forecast on strong medical device sales [2024-10-16 07:37AM]
18-07-2024	PM		ABT	Abbott Laboratories	179,110	1.14	1.10	1.08	Abbott Laboratories Non-GAAP EPS of $1.14 beats by $0.04, revenue of $10.4B beats by $30M [7/18/2024 7:31 AM]	99.95	-4.73 (-4.51%)	102.59	-2.09 (-2.00%)	89.67 - 121.64	10,356,040	6,140,000	96,879
Abbott Q2 Earnings Preview: Strong fundamentals to see through a good quarter [7/17/2024 1:14 PM] Abbott Laboratories Non-GAAP EPS of $1.14 beats by $0.04, revenue of $10.4B beats by $30M [7/18/2024 7:31 AM] Earnings Summary: Abbott Laboratories tops consensus in Q2, raises FY2024 EPS outlook [7/18/2024 7:47 AM] Abbott Laboratories in charts: Medical Devices maintains Y/Y double-digit growth momentum in Q2 [7/18/2024 8:00 AM] Abbott raises 2024 outlook after MedTech strength in Q2 [7/18/2024 9:05 AM]
17-04-2024	PM		ABT	Abbott Laboratories	188,940	0.98	0.95	1.03	Abbott Laboratories Non-GAAP EPS of $0.98 beats by $0.03, raises midpoint of FY guidance ranges [4/17/2024 7:31 AM]	106.15	-3.06 (-2.80%)	108.58	-0.63 (-0.58%)	89.67 - 121.64	10,355,100	4,910,000	120,433
Abbott posts Q1 beat on MedTech even as diagnostics slump [4/17/2024 8:32 AM] Abbott in charts: Q1 sees strong results in Medical Devices and Established Pharmaceuticals [4/17/2024 7:47 AM] Abbott Laboratories Non-GAAP EPS of $0.98 beats by $0.03, raises midpoint of FY guidance ranges [4/17/2024 7:31 AM] Abbott Q1 Earnings Preview: Return of core business strength could benefit top line [4/16/2024 1:10 PM]
24-01-2024	PM		ABT	Abbott Laboratories	198,240	1.19	1.19	1.03	Abbott Laboratories Non-GAAP EPS of $1.19 in-line, revenue of $10.24B beats by $50M [1/24/2024 7:33 AM]	110.69	-3.31 (-2.90%)	111.00	-3.00 (-2.63%)	89.67 - 115.83	6,673,578	5,010,000	101,374
Earnings preview: Abbott slated to roll out Q4 results Wednesday [1/23/2024 2:11 PM] Abbott Laboratories Non-GAAP EPS of $1.19 in-line, revenue of $10.24B beats by $50M [1/24/2024 7:33 AM] Abbott in charts: Medical Devices and Nutrition segment maintains double-digit growth momentum in Q4 [1/24/2024 8:00 AM] Abbott Q4 beat driven by MedTech [1/24/2024 8:13 AM]
18-10-2023	PM		ABT	Abbott Laboratories	159,970	1.14	1.10	1.15	Abbott Laboratories Non-GAAP EPS of $1.14 beats by $0.04, revenue of $10.14B beats by $320M [10/18/2023 7:31 AM]	95.69	3.55 (3.85%)	96.00	3.86 (4.19%)	89.67 - 115.83	13,778,159	6,020,000	743,144
Abbott looks to continue long streak of EPS, revenue beats in Q3 [10/17/2023 11:00 AM] Abbott Laboratories Non-GAAP EPS of $1.14 beats by $0.04, revenue of $10.14B beats by $320M [10/18/2023 7:31 AM] Abbott beats in Q3 despite post-COVID headwinds to diagnostics [10/18/2023 8:17 AM] Abbott in charts: Medical Devices and Nutrition segment sales saw double-digit growth Y/Y in Q3 [10/18/2023 8:15 AM] Diabetes device stocks gain after Abbott CEO downplays GLP-1 threat [10/18/2023 2:54 PM]
20-07-2023	PM		ABT	Abbott Laboratories	186,070	1.08	1.04	1.43	Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M [7/20/2023 7:30 AM]	111.74	4.46 (4.16%)	108.00	0.72 (0.67%)	93.25 - 115.69	7,274,324	4,810,000	80,517
Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M [7/20/2023 7:30 AM] Abbott Q2 results top consensus as base business offsets COVID impact [7/20/2023 8:20 AM]
19-04-2023	PM	7:30 AM ET (Apr 19)	ABT	Abbott Laboratories	180,680	1.03	0.98	1.73	Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.05, revenue of $9.7B beats by $60M [4/19/2023 7:18 AM]	112.33	8.17 (7.85%)	108.00	3.85 (3.70%)	93.25 - 124.35	10,750,010	5,560,000	81,296
All eyes on Abbott Q1 results amid baby formula woes and device recall [4/18/2023 11:49 AM] Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.05, revenue of $9.7B beats by $60M [4/19/2023 7:18 AM] Abbott stock pops as sales grow on medical devices amid COVID test slowdown [4/19/2023 8:07 AM] Hot Stocks: ABT, TRV rise on earnings; crypto, EV stocks slide; BBBY surges [4/19/2023 12:57 PM]
25-01-2023	PM	7:30 AM ET (Jan 25)	ABT	Abbott Laboratories	198,780	1.03	0.90	1.32	Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.10, revenue of $10.1B beats by $410M [1/25/2023 7:30 AM]	110.74	-1.79 (-1.59%)	111.00	-1.53 (-1.36%)	93.25 - 130.93	4,596,412	5,300,000	71,294
Abbott Q4 results in focus as DOJ probe on baby formula plant looms [1/24/2023 11:03 AM] Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.10, revenue of $10.1B beats by $410M [1/25/2023 7:30 AM] Abbott posts 12% revenue drop amid baby formula disruption, waning COVID impact [1/25/2023 8:37 AM]
19-10-2022	PM	7:30 AM ET (Oct 19)	ABT	Abbott Laboratories	181,290	1.15	0.90	1.40	Abbott Laboratories raises full-year profit guidance, Non-GAAP EPS of $1.15 beats by $0.21, revenue of $10.4B beats by $750M [10/19/2022 7:33 AM]	98.30	-6.68 (-6.36%)	101.25	-3.73 (-3.55%)	96.32 - 142.60	16,086,894	6,070,000	327,191
Can Abbott maintain EPS beat run in Q3 as industry faces slowdown in COVID products demand? [10/18/2022 12:17 PM] Abbott Laboratories raises full-year profit guidance, Non-GAAP EPS of $1.15 beats by $0.21, revenue of $10.4B beats by $750M [10/19/2022 7:33 AM] Abbott Q3 topline contracts amid falling COVID-19 testing and baby formula issue [10/19/2022 8:15 AM] Abbott falls 8% to hit 52-week low despite Q3 beat [10/19/2022 12:30 PM] Abbott Reports Third-Quarter 2022 Results and Raises Full-Year EPS Guidance [Oct-19-22 07:30AM] The Zacks Analyst Blog Highlights Apple, Abbott Laboratories, International Business Machines, Estee Lauder and Progressive [Oct-18-22 07:25AM]
20-07-2022	PM	7:30 AM ET (Jul 20)	ABT	Abbott Laboratories	190,538	1.43	1.07	0.00	Abbott Laboratories Non-GAAP EPS of $1.43 beats by $0.29, revenue of $11.3B beats by $930M, raises full-year EPS guidance [7/20/2022 7:32 AM]	108.33	-1.60 (-1.46%)	106.92	-3.01 (-2.74%)	101.24 - 142.60	5,507,334	4,600,000	708,391
All eyes on Abbott Q2 results amid potential impact due to baby formula woes [7/19/2022 11:59 AM] Abbott Laboratories Non-GAAP EPS of $1.43 beats by $0.29, revenue of $11.3B beats by $930M, raises full-year EPS guidance [7/20/2022 7:32 AM] Abbott raises guidance as COVID-19 testing sales drive 2Q beat [7/20/2022 8:01 AM]
20-04-2022	PM	7:30 AM ET (Apr 20)	ABT	Abbott Laboratories	205,080	1.73	1.47	1.32	Abbott Laboratories Non-GAAP EPS of $1.73 beats by $0.27, revenue of $11.9B beats by $900M [4/20/2022 7:31 AM]	122.98	3.01 (2.50%)	118.40	-1.58 (-1.32%)	105.36 - 142.60	6,961,756	4,780,000	62,787
Abbott Laboratories Non-GAAP EPS of $1.73 beats by $0.27, revenue of $11.9B beats by $900M [4/20/2022 7:31 AM] Abbott Laboratories declares $0.47 dividend [4/20/2022 8:03 AM] Abbott beats revenue, profit estimates on strong COVID test demand; 2022 forecast unchanged [4/20/2022 8:29 AM] Hot Stocks: IBM, ABT rally on earnings news; BKR, PACW fall [4/20/2022 12:03 PM] Why Abbott (ABT) Could Beat Earnings Estimates Again [Apr-19-22 12:10PM] 3 Things About Abbott Laboratories That Smart Investors Know [Apr-19-22 10:45AM] Abbott Reports First-Quarter 2022 Results [Apr-20-22 07:30AM] Abbott profit jumps on COVID testing demand, strong medical device sales [Apr-20-22 07:40AM] Dow Jones Futures Rise, But Netflix Crashes On Earnings; Tesla Earnings Due [Apr-20-22 08:09AM] Abbott reported $3.3 billion in sales of COVID-19 tests in the first quarter [Apr-20-22 08:00AM] Dow Jones Futures Rise, But Netflix Crashes 27% On Earnings; Tesla Earnings Due [Apr-20-22 08:29AM] Abbott Beats Expectations, but Doesnt Expect Covid-19 Test Sales to Last [Apr-20-22 09:17AM] Dow Jones Rises, But Netflix Crashes 30% On Earnings; Tesla Earnings Due [Apr-20-22 09:33AM] Abbott falls on 'conservative' profit outlook despite COVID-19 testing strength [Apr-20-22 07:40AM] Abbott Labs First-Quarter Results Top Estimates, Earnings Outlook Short [Apr-20-22 09:50AM] Abbott Beats Expectations, as Covid-19 Test Sales Provide Boost [Apr-20-22 09:42AM] Abbott (ABT) Surpasses Q1 Earnings and Revenue Estimates [Apr-20-22 08:45AM] Dow Jones Rises, But Netflix Crashes 34% On Earnings; Tesla Earnings Due [Apr-20-22 10:01AM] Abbott Labs tops earnings estimates as COVID-19 test sales surge [Apr-20-22 09:54AM] Face-mask issue remains hot COVID topic as poll finds most Americans support their use on public transport and DoJ awaits CDCs decision [Apr-20-22 10:16AM] Abbott cuts sales growth forecast on baby formula recall [Apr-20-22 07:40AM] Abbott's (ABT) Q1 Earnings and Revenues Exceed Estimates [Apr-20-22 10:23AM] Abbott predicts fewer sales of COVID-19 tests in 2022 but says the business of at-home tests isnt going away [Apr-20-22 12:25PM] Abbott Laboratories (ABT) Q1 2022 Earnings Call Transcript [Apr-20-22 03:00PM] Lucky Charms Sickness Complaints Spread Rapidly, Adding Complexity to Safety Probe [Apr-20-22 05:35PM] Earnings preview: Tesla, Procter & Gamble, Verizon set to report this week [Apr-20-22 03:56PM]
26-01-2022	PM	7:30 AM ET (Jan 26)	ABT	Abbott Laboratories	218,950	1.32	1.18	1.45	Abbott Laboratories Non-GAAP EPS of $1.32 beats by $0.11, revenue of $11.5B beats by $790M [1/26/2022 7:31 AM]	120.24	-3.03 (-2.46%)	119.52	-3.75 (-3.04%)	105.36 - 142.60	12,726,601	7,920,000	104,140
Will Abbott Laboratories maintain EPS beat run in Q4 amid COVID challenges? [1/25/2022 11:02 AM] Abbott Laboratories Non-GAAP EPS of $1.32 beats by $0.11, revenue of $11.5B beats by $790M [1/26/2022 7:31 AM] Abbott beats Street estimates on top and bottom lines; COVID-19 testing sales reached $2.3B [1/26/2022 8:17 AM] First Command Advisory Services, Inc. Buys iShares MSCI Intl Multifactor ETF, Schwab US ... [Jan-25-22 05:38PM] SWS Partners Buys Abbott Laboratories, Cognizant Technology Solutions Corp, American Homes 4 ... [Jan-25-22 01:38PM] Peterson Wealth Advisors, LLC Buys Microsoft Corp, Exxon Mobil Corp, The Walt Disney Co, Sells ... [Jan-25-22 01:38PM] Tesla, Abbott Labs, Intel Earnings: 3 Things to Watch [Jan-25-22 11:30AM] PDS Planning, Inc Buys Apple Inc, iShares Core U.S. ... [Jan-25-22 09:38AM] Railway Pension Investments Ltd Buys Abbott Laboratories, Alphabet Inc, Advanced Micro Devices ... [Jan-25-22 09:38AM] Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast [Jan-26-22 07:30AM] Abbott sold $2.3 billion in COVID-19 tests in the fourth quarter [Jan-26-22 08:05AM] Abbott Labs Crushes Quarterly Views On Strong Covid Tests, But Shares Fall On Weak Outlook [Jan-26-22 09:01AM] UPDATE 3-Abbott beats profit, sales estimates on strong COVID test demand [Jan-26-22 07:49AM] Abbott beats profit, sales estimates on strong COVID test demand [Jan-26-22 07:37AM] Abbott Beats Earnings Expectations. The Stock is Down. [Jan-26-22 09:32AM] Abbott Beats Earnings Expectations. The Stock Is Down. [Jan-26-22 09:32AM] Stocks Gain as Tech Rallies, Investors Await Fed [Jan-26-22 10:25AM] Stock Markets Trade Higher Ahead Of Fed Decision; Microsoft Issues Upbeat Earnings, Guidance [Jan-26-22 10:42AM] Abbott (ABT) Q4 Earnings and Revenues Surpass Estimates [Jan-26-22 08:45AM] Abbott profit, sales beat estimates on vigorous COVID test demand [Jan-26-22 07:37AM] UPDATE 4-Abbott profit, sales beat estimates on vigorous COVID test demand [Jan-26-22 07:49AM] Stock Markets Trade Higher Ahead Of Fed Decision; Microsoft Earnings Upbeat [Jan-26-22 10:42AM] Stock Market Trades Higher Ahead Of Fed Decision; Microsoft Earnings Upbeat [Jan-26-22 10:42AM] Abbott's (ABT) Q4 Earnings and Revenues Beat Estimates [Jan-26-22 10:47AM] Financial Advantage, Inc. Buys Hartford Total Return Bond ETF, Eli Lilly and Co, Abbott ... [Jan-26-22 01:38PM] Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript [Jan-26-22 05:30PM]
20-10-2021	PM	7:15 AM ET (Oct 20)	ABT	Abbott Laboratories	207,100	1.40	0.92	0.98	Abbott Laboratories EPS beats by $0.46, beats on revenue, boost FY guidance [10/20/2021 7:31 AM]	123.37	4.03 (3.38%)	124.48	5.14 (4.31%)	103.13 - 129.70	7,412,725	5,180,000	133,860
Abbott Laboratories Q3 earnings preview and review [10/19/2021 2:10 PM] Can Abbott Laboratories Q3 earnings bring positive surprise? [10/19/2021 12:07 PM] Abbott Laboratories EPS beats by $0.46, beats on revenue, boost FY guidance [10/20/2021 7:31 AM] Abbott raises 2021 guidance following strong growth for COVID-19 tests [10/20/2021 8:37 AM] 5 Must-See Earnings Charts This Week [Oct-19-21 05:30PM] Abbott and Real Madrid Team Up to Support the Health and Nutrition of Children Globally [Oct-19-21 01:36PM] Abbott's (ABT) Nutrition Arm in Focus on Real Madrid Alliance [Oct-19-21 10:50AM] Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance [Oct-20-21 07:30AM] Abbott Laboratories stock surges after big profit and sales beats, and upbeat full-year outlook [Oct-20-21 07:44AM] Abbott raises annual profit forecast after upbeat quarterly results [Oct-20-21 07:36AM] UPDATE 1-Abbott raises annual profit forecast after upbeat quarterly results [Oct-20-21 07:43AM] Abbott Labs Earnings Beat Estimates. Its Stock Is Rising. [Oct-20-21 08:05AM] Abbott raises annual earnings outlook as COVID-19 test sales rebound [Oct-20-21 07:36AM] UPDATE 2-Abbott raises annual earnings outlook as COVID-19 test sales rebound [Oct-20-21 07:43AM] Abbott Labs Squashes Quarterly Views As Covid Testing Sales Pop [Oct-20-21 09:18AM] Alibaba, Verizon Rise in Premarket; Netflix Falls [Oct-20-21 05:24AM] Abbott Jumps as Covid Tests Boost Earnings, Guidance [Oct-20-21 05:09AM] US STOCKS-Wall St grinds higher on solid healthcare earnings; supply woes linger [Oct-20-21 10:08AM] Abbott (ABT) Q3 Earnings and Revenues Beat Estimates [Oct-20-21 08:45AM] Abbott Labs Earnings Are Astounding! Here's My Trade Idea [Oct-20-21 06:30AM] Novavax vaccine delays slump stock, Abbott Labs raises guidance, Biogen beats Q3 estimates [Oct-20-21 10:35AM] UPDATE 3-Abbott raises annual earnings outlook as COVID-19 test sales rebound [Oct-20-21 07:43AM] US STOCKS-S&P 500, Dow near record highs on solid forecasts from healthcare firms [Oct-20-21 12:20PM] Pre-Markets Opens Flat [Oct-20-21 10:46AM] Markets Flat as Q3 Earnings Continue: VZ, ABT, TSLA & More [Oct-20-21 10:36AM] Abbott's (ABT) Q3 Earnings Beat Estimates, 2021 Guidance Up [Oct-20-21 10:29AM] Abbott Stock Faces Resistance At A Key Line As A Wild Card Obscures 2022 [Oct-20-21 01:07PM] Why Abbott Shares Are Rising Today [Oct-20-21 10:01AM] Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript [Oct-20-21 02:00PM] US STOCKS-S&P 500, Dow near records as earnings reports soothe investor fears [Oct-20-21 03:10PM] US STOCKS-Wall Street closes higher as earnings reports soothe investor fears [Oct-20-21 04:56PM] Why Abbott Laboratories Shot Higher Today [Oct-20-21 04:34PM] Abbott Labs Stock Leapfrogs A Key Line Despite A Wild Card Obscuring 2022 [Oct-20-21 04:09PM] REFILE-US STOCKS-Wall Street closes higher as earnings reports soothe investor fears [Oct-20-21 04:01PM]
22-07-2021	PM	7:30 AM ET (Jul 22)	ABT	Abbott Laboratories	210,960	1.17	1.01	0.57	Abbott Laboratories EPS beats by $0.15, beats on revenue [7/22/2021 7:16 AM]	118.19	-0.79 (-0.66%)	117.85	-1.13 (-0.95%)	98.00 - 128.54	5,421,158	4,610,000	18,457
Abbott Laboratories Q2 2021 Earnings Preview [7/21/2021 1:48 PM] Abbott Laboratories EPS beats by $0.15, beats on revenue [7/22/2021 7:16 AM] Abbott accelerates quarterly growth as medical devices outperform diagnostics [7/22/2021 8:14 AM] Chip Shortages, Jobless Claims, ECB, Musk Lifts Bitcoin - What's Moving Markets [Jul-22-21 02:36AM] Abbott Reports Second-Quarter 2021 Results [Jul-22-21 07:15AM] UPDATE 1-Abbott profit more than doubles as medical device sales rebound [Jul-22-21 07:37AM] Abbott profit more than doubles as medical device sales rebound [Jul-22-21 07:25AM] Abbott Labs stock gains after profit more than doubles, sales rise above expectations [Jul-22-21 07:39AM] Abbott beats profit estimates as medical device sales rebound [Jul-22-21 07:25AM] UPDATE 2-Abbott beats profit estimates as medical device sales rebound [Jul-22-21 07:37AM] Abbott Labs Beats Second-Quarter Views, But Covid Testing Demand Dives [Jul-22-21 08:49AM] Abbott (ABT) Surpasses Q2 Earnings and Revenue Estimates [Jul-22-21 08:35AM] Abbott Hits The Skids As Covid Testing Demand Falls Off Despite Quarterly Beat [Jul-22-21 11:27AM] Quest Q2 Earnings Ahead Of Expectation On Recovery Of Non-COVID Business, Issues Mixed FY21 Guidance [Jul-22-21 09:21AM] Abbott (ABT) Q2 Earnings Beat, Molecular Diagnostic Sales Drop [Jul-22-21 11:04AM] Abbott Laboratories (ABT) Q2 2021 Earnings Call Transcript [Jul-22-21 01:00PM]
20-04-2021	PM	7:30 AM ET (Apr 20)	ABT	Abbott Laboratories	220,290	1.32	1.33	0.65	Abbott Laboratories EPS beats by $0.05, misses on revenue [4/20/2021 7:31 AM]	119.87	-4.66 (-3.74%)	120.52	-4.01 (-3.22%)	86.16 - 128.54	8,915,454	4,750,000	126,603
Abbott Laboratories EPS beats by $0.05, misses on revenue [4/20/2021 7:31 AM] Abbott Laboratories stock falls as 2021 guidance misses estimates [4/20/2021 8:13 AM] Abbott's Fast, Reliable and Convenient COVID-19 Tests Help the Philippines Fight Infection Surge [Apr-19-21 06:00PM] UPDATE 2-CVS to offer three over-the-counter COVID-19 tests for use at home [Apr-19-21 09:49AM] Abbott Begins Shipping BinaxNOW COVID-19 Ag Self Test to Retailers Today [Apr-19-21 08:30AM] Abbott Reports First-Quarter 2021 Results [Apr-20-21 07:30AM] Abbott Labs Earnings, Sales Miss; ABT Stock Falls [Apr-20-21 07:42AM] Abbott's stock drops 3%, though earnings more than tripled for the medical test company in the first quarter [Apr-20-21 08:02AM] Abbott quarterly sales miss estimates on lower COVID-19 test volumes [Apr-20-21 07:41AM] UPDATE 2-Abbott quarterly sales miss estimates on lower COVID-19 test volumes [Apr-20-21 07:44AM] Walgreens (WBA) Inks Deal to Expand COVID-19 Testing Access [Apr-20-21 07:57AM] Abbott Drops on Mixed Results and Lagging Guidance [Apr-20-21 05:07AM] Abbott (ABT) Q1 Earnings and Revenues Miss Estimates [Apr-20-21 08:55AM] What Abbott's 'Rare, Off-Color' Earnings Say About The Covid Testing Scene [Apr-20-21 09:54AM] Abbott (ABT) Q1 Earnings Miss, Diagnostic Test Sales Solid [Apr-20-21 09:49AM] Abbott's Sales Soared in Q1, but Not Enough to Satisfy Wall Street [Apr-20-21 11:22AM] Abbott sales miss signals slowing COVID-19 tests demand as vaccinations take off [Apr-20-21 07:41AM] Abbott Laboratories (ABT) Q1 2021 Earnings Call Transcript [Apr-20-21 02:30PM] Abbott Laboratories Shares Slump as Q1 Earnings and Revenue Fall Shy of Expectations [Apr-20-21 10:04AM] Abbott Laboratories Shares Sink on Mixed Q1; New Dividend Declared [Apr-20-21 05:07PM]
27-01-2021	PM	7:30 AM ET (Jan 27)	ABT	Abbott Laboratories	203,330	1.45	1.36	0.95	Abbott Laboratories EPS beats by $0.10, beats on revenue [1/27/2021 7:33 AM]	114.40	-0.34 (-0.29%)	115.52	0.79 (0.69%)	61.61 - 117.78	7,675,313	4,849,227	58,687
Abbott Laboratories EPS beats by $0.10, beats on revenue [1/27/2021 7:33 AM] Abbott Laboratories Q4 2020 Earnings Preview [1/26/2021 1:12 PM] Abbott's Panbio rapid antigen test scores CE mark for two new uses [1/26/2021 7:59 AM] Abbott tops Q4 consensus, COVID-19 testing-related sales of $2.4B [1/27/2021 8:04 AM] Here's How Abbott Labs Hit a Home Run With Its Q4 Results [Jan-27-21 03:00PM] Durable Goods Orders For December Rose Lower-than-Expected [Jan-27-21 10:49AM] Abbott (ABT) Q4 Earnings Top, Diagnostic Test Sales Solid [Jan-27-21 10:42AM] P/E Ratio Insights for Abbott Laboratories [Jan-27-21 09:54AM] Abbott Laboratories: Q4 Earnings Insights [Jan-27-21 08:15AM] Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021 [Jan-27-21 07:30AM] What Does Abbott's Debt Look Like? [Jan-27-21 07:21AM] Earnings Preview: Abbott Laboratories [Jan-26-21 10:10AM] Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab [Jan-26-21 07:45AM] 2 Stocks I'll Hold Forever [Jan-26-21 07:16AM]
21-10-2020	PM	7:30 AM ET (Oct 21)	ABT	Abbott Laboratories	194,170	0.98	0.90	0.84	Abbott Laboratories EPS beats by $0.07, beats on revenue [10/21/2020 7:32 AM]	106.13	-2.23 (-2.06%)	109.90	1.54 (1.42%)	61.61 - 114.20	4,907,622	4,054,405	89,938

16-07-2020	PM	7:30 AM ET (Jul 16)	ABT	Abbott Laboratories	167,740	0.57	0.43	0.82	Abbott Laboratories EPS beats by $0.15, beats on revenue [7/16/2020 7:36 AM]	94.92	-1.81 (-1.87%)	97.70	0.97 (1.00%)	61.61 - 100.00	3,932,314	4,248,465	103,953